Q2 revenue and earnings beats didn't make up for the company's full-year guidance cut.Shares of Integra Lifesciences (IART -17.88%) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the market opened.Integra reported Q2 revenue of $418.2 million, up 9.7% year over year. This topped the average analyst revenue estimate of nearly $413.2 million.The company posted a loss per share of $0.16, based on generally accepte ...